<DOC>
	<DOCNO>NCT01602367</DOCNO>
	<brief_summary>The purpose study determine whether BMS-823778 safe effective treatment hypertension overweight obese patient .</brief_summary>
	<brief_title>Safety Efficacy Study BMS-823778 Treat Uncontrolled High Blood Pressure Overweight Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Qualifying seat blood pressure ≥90 ≤105 mmHg diastolic AND ≤155 mmHg systolic Mean 24hour diastolic blood pressure ≥85 mmHg Body mass index ( BMI ) ≥27 kg/m2 If receiving oral antihyperglycemic medication cholesterol lower medication , receive stable dose least 6 week History Cushing 's disease syndrome , Addison 's disease Glycosylated hemoglobin ( HbA1c ) ≥10 % Cerebrovascular insult , unstable angina , myocardial infarction ( MI ) within 6 month History impair renal hepatic function BMI ≥50 kg/m2 Any injectable antihyperglycemic agent ( insulin ) within 16 week Currently receive one class antihypertensive agent within 4 week Daily use nonsteroidal antiinflammatory agent within 1 week Use androgen medication , include topical preparation , within 6 week Diagnosis history breast cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>